Top Injectable Manufacturer in Uzbekistan – Reliable Pharmaceutical Solutions
- Maulik Sudani
- Jul 19
- 10 min read
Last Updated: July 19, 2026
TL;DR: Uzbekistan — Central Asia's most populous country, served by a Ministry of Health network that runs from republican specialised scientific-practical medical centres in Tashkent through regional (viloyat) multidisciplinary medical centres to district hospitals and rural physician points — imports more than 80% of the medicines its patients use, which puts a permanent premium on reliable, compliant sterile injectable supply. Every medicine placed on the market must hold state registration: the dossier is filed in CTD/eCTD format with the Center for Pharmaceutical Products Safety under the Ministry of Health, the executive body of the Pharmaceutical Industry Development Agency; a new state registration regulation took effect on 26 February 2026; the registration certificate is valid for five years; legalised GMP certificates are required for every manufacturing site in the chain; and the summary of product characteristics and instruction for use must be supplied in Uzbek. Since 1 October 2025 a recognition route has been open for products already registered by WHO Listed Authorities and GBT Maturity Level 4 regulators, and since 1 January 2023 only GMP-compliant manufacturers may compete for public procurement — now consolidated onto a unified national e-procurement platform. Farbe Firma Pvt Ltd is a WHO-GMP certified injectable manufacturer and CDMO in Gujarat, India, producing more than 100 sterile injectables under ISO Class 5 aseptic conditions and exporting to 30+ countries, with complete CTD/ACTD and eCTD dossiers, drug master files and ICH Q1A stability data ready to support Uzbek state registration, GMP assessment and tender participation.
Key Takeaways
Market and regulatory pathway: state registration is granted through the Center for Pharmaceutical Products Safety under the Ministry of Health — the executive body of the Pharmaceutical Industry Development Agency — with the dossier filed in CTD/eCTD format, a new registration regulation in force since 26 February 2026, a certificate valid for five years, legalised GMP certificates for every manufacturing site, and the SmPC and instruction for use in Uzbek; a recognition route has been open since 1 October 2025 for products already approved by WHO Listed Authorities and GBT Maturity Level 4 regulators. Farbe Firma builds every dossier around these requirements and around the demand channelled through Ministry of Health facilities and the unified national e-procurement platform.
Certified manufacturing: a WHO-GMP certified plant with an ISO Class 5 aseptic core, validated water-for-injection loops, terminal moist-heat sterilisation wherever the formulation allows it and validated aseptic filling where it does not, backed by continuous environmental monitoring, routine media fills and container-closure integrity testing on every campaign — precisely the evidence base an Uzbek GMP assessment and a tender qualification both look for.
Procurement-ready documentation: since 1 January 2023 only manufacturers producing to GMP standards may bid for state procurement, and bids are submitted in Uzbek or Russian. Farbe Firma supplies the legalised GMP certificates, Certificates of Pharmaceutical Product, batch manufacturing and analytical records, stability summaries and process validation packages that importers and their local partners need in order to qualify, price and defend a submission on the national e-platform.
Logistics and resilience for a double-landlocked market: air freight into Tashkent International Airport plus rail and road corridors through Kazakhstan, the Trans-Caspian route and Iranian gateway ports, supported by ICH Q1A stability data covering Zone II conditions and hot, dry continental summer extremes, freeze-protected winter shipping for aqueous injectables, and shelf-life planning built deliberately around the five-year registration cycle.
Introduction: Why an Injectable Manufacturer in Uzbekistan Must Meet Global Standards
Uzbekistan is the most populous country in Central Asia, and its healthcare system is built in clear tiers: republican specialised scientific-practical medical centres in Tashkent that concentrate cardiology, oncology, surgery, paediatrics and infectious-disease expertise; regional (viloyat) multidisciplinary medical centres serving each province; district and city hospitals; and a primary-care layer of rural physician points that reaches communities well beyond the main urban corridors. Sterile injectables sit at the centre of what all of those tiers actually do. Anaesthesia and surgical care, obstetric emergencies, trauma, oncology day-care, intensive-care support, antibiotic therapy for hospitalised patients and routine electrolyte and fluid management are all delivered by injection, and none of them tolerate a supply gap or a quality failure. When a viloyat hospital in Samarkand, Bukhara, Namangan or Nukus schedules a surgical list, the assumption that the vial on the trolley is sterile, correctly labelled, in date and consistent with the last batch is not a preference — it is the precondition for the procedure going ahead at all.
That demand is met overwhelmingly from abroad. Uzbekistan's medicines market is estimated at roughly USD 1.8–2 billion, and imports account for more than 80% of total medicine consumption, with India already supplying a substantial share. The government is working hard to change that balance — national policy targets lifting domestic pharmaceutical output toward USD 10 billion by 2035, and Uzbekistan is positioning itself as a manufacturing and distribution gateway into the wider CIS pharmaceutical market. A dedicated India–Uzbekistan pharmaceutical and nutraceutical trade corridor has been launched to formalise exactly this flow. For the foreseeable future, however, a very large share of the country's injectable requirement will continue to be imported, and that makes the choice of manufacturing partner a strategic decision rather than a purchasing one. An importer who selects a plant that cannot produce a legalised GMP certificate, cannot supply a clean CTD dossier, or cannot hold a specification steady across three years of repeat orders will discover the problem at the worst possible moment: at registration, at renewal, or in the middle of a tender award.
What Sets a World-Class Injectable Manufacturer in Uzbekistan Apart
The first differentiator is genuine sterile-manufacturing capability, not a general oral-solids plant with a filling line attached. Sterile injectables are made in classified cleanrooms with an ISO Class 5 critical zone, fed by validated water-for-injection loops and pure-steam systems, with personnel flows, gowning qualification and material airlocks designed to keep the aseptic core intact. Where a formulation is heat-stable, terminal moist-heat sterilisation is used because it delivers the highest and most defensible sterility assurance level; where the molecule will not survive an autoclave cycle, validated aseptic processing takes over, supported by routine media fills that challenge the process with a growth medium rather than product. Around that sit continuous environmental monitoring, container-closure integrity testing, bacterial endotoxin testing by LAL, sterility testing, HPLC and GC assay and related-substance work, and Karl Fischer moisture determination for lyophilised presentations. A manufacturer that cannot show that stack of controls in an audit is not a serious candidate for a market where the regulator inspects and the tender rules screen on GMP.
The second differentiator is registration and market-access support built specifically around the Uzbek pathway. State registration is administered by the Center for Pharmaceutical Products Safety under the Ministry of Health, the executive body of the Pharmaceutical Industry Development Agency, and a new regulation governing the state registration of medicines — original, generic, biosimilar and biotechnological alike — took effect on 26 February 2026. The dossier is prepared in CTD/eCTD format and must be accompanied by legalised GMP certificates covering every manufacturing site involved in the chain, with the summary of product characteristics and the instruction for use provided in Uzbek. The resulting registration certificate runs for five years, so renewal planning is part of the original filing strategy, not an afterthought. Since 1 October 2025 there has also been a recognition route for products already registered by WHO Listed Authorities and regulators assessed at Maturity Level 4 under the WHO Global Benchmarking Tool, which can materially shorten the timeline for a well-credentialed product. A manufacturer that already writes to CTD standards, keeps drug master files current and can turn around a regulator's question in days rather than months is worth far more to an importer than a marginally lower unit price.
Quality Systems Behind Every Batch We Ship to Uzbekistan
Every Farbe Firma injectable batch destined for Uzbekistan is released only after a full stack of testing is complete and reviewed. Identity, assay and related substances are determined by validated HPLC and GC methods; residual solvents are controlled to ICH limits; water content in lyophilised and powder-filled presentations is measured by Karl Fischer titration; bacterial endotoxins are quantified by LAL; sterility is confirmed under the compendial method; and particulate matter, pH, fill volume, closure integrity and visual inspection are all recorded against pre-set acceptance criteria. Specifications are written to USP, BP, IP or EP as the customer's market requires, and the certificate of analysis issued with each consignment reports actual measured results rather than a generic conformity statement, so an Uzbek importer, a regional hospital pharmacy or a tender evaluator can see the data instead of taking it on trust.
Around those release tests sits a deeper quality architecture. Water-for-injection generation and distribution loops are validated and continuously monitored; sterilisation and depyrogenation cycles are qualified against biological and chemical indicators; cleaning validation demonstrates that changeover between products leaves no meaningful carry-over; and stability is run to ICH Q1A with photostability to ICH Q1B, generating the long-term and accelerated data that a five-year Uzbek registration and its renewal both depend on. Change control, deviation management, out-of-specification investigation and annual product quality review are documented under a quality management system built for inspection, with electronic records kept under data-integrity controls and full audit trails. This is the same evidence base that supports the legalised GMP certificates an Uzbek dossier requires — which is why audit readiness is treated as a continuous state here, not a project started when an inspection is announced.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Injectable Manufacturer in Uzbekistan for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables at its WHO-GMP certified facility in Gujarat, India, and exports to over 30 countries across Asia, Africa, the Middle East, the CIS and Latin America. The portfolio spans the therapeutic categories that Uzbek hospitals consume in volume: anaesthetics and analgesics, antibiotics and antifungals, cardiovascular and emergency medicines, oncology support, corticosteroids, antiemetics, vitamins and electrolytes, and large-volume and small-volume parenterals in ampoules, vials, lyophilised presentations and prefilled formats. For an importer assembling a registration programme or a hospital-supply portfolio, that breadth means a single qualified, audited, already-documented source can cover a wide slice of the requirement instead of forcing a patchwork of small suppliers with inconsistent paperwork and unpredictable lead times.
Our CDMO services scale cleanly from a single distributor's launch portfolio to full hospital-tender volumes. Contract and third-party manufacturing runs under the customer's brand with artwork, pack size and language configured for the destination — including Uzbek-language cartons, labels and instructions for use alongside Russian where a customer's channel requires it — and technical transfer is handled by a team that has taken products from development batches through validation to commercial supply many times. Because Farbe Firma is a manufacturer rather than a trading intermediary, an Uzbek partner deals directly with the people who own the process: the same organisation answers the regulatory question, schedules the campaign, releases the batch and stands behind the certificate of analysis.
Buyers stay with Farbe Firma because of audit-readiness and communication. Uzbek importers and their local regulatory consultants receive complete CTD/eCTD dossier modules, drug master files, legalised GMP certificates, Certificates of Pharmaceutical Product, ICH Q1A stability packages, process validation reports and batch documentation in the formats the Center for Pharmaceutical Products Safety expects, and they receive them quickly. For a double-landlocked market the logistics discipline matters just as much: consignments move by air freight into Tashkent International Airport or by rail and road corridors through Kazakhstan, the Trans-Caspian route and Iranian gateway ports, with temperature-controlled handling, freeze-protection for aqueous injectables during the continental winter, and stability data that covers the hot, dry summer extremes of the region. Combined with realistic lead times and shelf life planned around the five-year registration cycle, that is what turns a first trial order into a decade-long supply relationship.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified injectable manufacturer that can supply Uzbekistan?
Yes. Farbe Firma Pvt Ltd is a WHO-GMP certified sterile injectable manufacturer and CDMO based in Gujarat, India, producing more than 100 injectable products under ISO Class 5 aseptic conditions and exporting to over 30 countries. We supply the legalised GMP certificates, Certificates of Pharmaceutical Product, site master file and batch documentation that Uzbek importers need for state registration with the Center for Pharmaceutical Products Safety and for qualification on the national public procurement platform.
How does Farbe Firma support medicine registration in Uzbekistan?
We provide complete CTD and eCTD dossier modules, drug master files, ICH Q1A stability data with ICH Q1B photostability, analytical method validation, process validation reports and the legalised GMP certificates required for every manufacturing site in the chain. Our regulatory team works with the importer or local representative through evaluation questions, supports Uzbek-language SmPC and instruction-for-use preparation, and plans renewal ahead of the five-year expiry of the registration certificate. Where a product qualifies under the recognition route introduced on 1 October 2025, we supply the supporting approval documentation as well.
Can Farbe Firma supply injectables for Uzbek state tenders and hospital procurement?
Yes. Since 1 January 2023 only manufacturers producing to GMP standards may participate in public procurement of pharmaceuticals in Uzbekistan, and state purchasing is being consolidated onto a unified national electronic platform with bids submitted in Uzbek or Russian. Farbe Firma supports importers and local partners bidding into that system with the technical dossier, GMP evidence, stability summaries, validated capacity commitments and pricing structure needed to qualify and to deliver reliably once an award is made.
How does Farbe Firma handle GMP evidence and logistics for a landlocked market like Uzbekistan?
Our facility is WHO-GMP certified and maintained in a continuous state of audit readiness, so legalised GMP certificates and the supporting quality documentation are available without delay. Because Uzbekistan is double-landlocked, we plan routing explicitly: air freight into Tashkent International Airport for urgent or high-value consignments, and rail or road movement through Kazakhstan, the Trans-Caspian corridor or Iranian gateway ports for volume shipments. Packaging and shipping are specified for the region's hot, dry summers and freezing winters, with temperature monitoring and freeze-protection for aqueous injectables.
What is the minimum order quantity for injectable contract manufacturing for Uzbekistan?
Minimum order quantities depend on the presentation, the batch size the formulation requires and whether the order is generic-labelled or brand-specific artwork. We deliberately keep entry volumes workable for a first registration batch or a market-entry consignment, then scale to full tender volumes as demand develops. Contact director@farbefirma.org with your product list, pack sizes, target registration timeline and destination and we will return an indicative quotation with lead times and the documentation package.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments